TATVA CHIN PHARM CHEM
TATVA · NSE
1,614.80
-13.00 (-0.80%)
as of 29 Oct 2026 close
Open
1,637.00
High
1,637.00
Low
1,581.00
Prev close
1,627.80
52w high
2,113.60
21 Oct 2026
52w low
1,044.10
30 Mar 2026
VWAP
1,604.04
Delivery %
42.3%
of volume
Volume 46,779 · turnover ₹7.50 Cr · NSE bhavcopy (official close) · history since 29 Jul 2021
- ISIN
- INE0GK401011
- Series
- EQ
- Listed on NSE
- 29 Jul 2021
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 19 Oct 2026, 06:11 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 207 |
| Other income | 3 |
| Total expenses | 190 |
| Operating margin | 15.1% |
| Finance costs | 3 |
| Depreciation | 11 |
| Profit before tax | 20 |
| Tax | 5 |
| Net profit | 15 |
| Net margin | 7.4% |
| EPS (₹) | 6.57 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison